News
Under-Eye Wrinkle Treatment: How to Reduce Puffiness and Fine Lines
As we age, the skin around our eyes begins to show signs of wear and tear, with under-eye wrinkles, puffiness, and dark circles becoming common concerns. These issues can make us look tired and older than we feel. Fortunately,...
News
Receptor Grade IGF-1 LR3: Expansive Research Potential
Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like Growth Factor-1 (IGF-1), has emerged as a molecule of significant interest in scientific research. This peptide, studied for its structural modifications and extended half-life, has been hypothesized to possess unique...
Business & Industry
API China 2025 kicks off with Industry Buzz on Day One
At the China Import and Export Fair Complex in Guangzhou, the 92nd edition of API China, the country's leading pharmaceutical trade fair, got off to a lively start. This industry-leading event, which is co-located with PHARMEX, PHARMPACK, and SINOPHEX,...
News
FDA Plans to Deploy AI Tools for Scientific Reviews
The US Food and Drug Administration has announced plans to deploy AI tools all across the agency in order to assist in conducting scientific reviews. Following the very successful completion of a pilot program that incorporated generative AI into...
News
The Ultimate Pain Relief Guide: Proven Tips to Manage Discomfort Naturally
Pain is something that we all go through somehow or some time. There is acute pain, like a sprain to your ankle, or chronic pain, like back pain. When pain is present, it often leads individuals to instinctively establish...
News
Medical Negligence in 2025: Pharma’s Role in Ensuring Patient Safety
In the ever-evolving world of healthcare, the role of pharmaceutical companies in ensuring patient safety has never been more significant. As we step into 2025, the landscape of medical negligence is undergoing critical changes. If you are seeking professional...
News
When Pharma Meets the Underworld: How Legitimate Drug Supply Chains and Illicit Drug Markets Collide
In today's global landscape, the intersection between legitimate pharmaceutical supply chains and illicit drug markets presents significant challenges. This confluence not only impacts public health but also raises legal and ethical concerns. If you are concerned about the legal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.